CFB
RDY icon

Cullen/Frost Bankers’s Dr. Reddy's Laboratories RDY Stock Holding History

Cullen/Frost Bankers’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,670
Closed -$61.6K – 1405
2025
Q1 		$61.6K Buy
+4,670
New +$64.4K ﹤0.01% 686

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cullen/Frost Bankers's RDY Position: Q2 2025 in Review

Cullen/Frost Bankers sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 4,670 shares — an estimated $61.6K sold.

Cullen/Frost Bankers first reported a position in RDY in Q1 2025 and held it in 1 quarter. The position peaked at $61.6K in Q1 2025. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Cullen/Frost Bankers reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • Cullen/Frost Bankers sold 4,670 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $61.6K.
  • Cullen/Frost Bankers first reported a position in Dr. Reddy's Laboratories in Q1 2025 and held it in 1 quarter.
  • Cullen/Frost Bankers's Dr. Reddy's Laboratories position peaked at $61.6K in Q1 2025.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Cullen/Frost Bankers's 13F filing for Q2 2025, filed 30 Jul 2025.